{"id":9895,"date":"2020-05-27T10:44:02","date_gmt":"2020-05-27T08:44:02","guid":{"rendered":"http:\/\/161.116.26.48\/?p=9895"},"modified":"2020-05-27T10:44:02","modified_gmt":"2020-05-27T08:44:02","slug":"iproteos-spin-off-ub-se-integra-accure-therapeutics","status":"publish","type":"post","link":"https:\/\/www.fbg.ub.edu\/es\/actualidad\/iproteos-spin-off-ub-se-integra-accure-therapeutics\/","title":{"rendered":"Iproteos, spin-off de la UB, se integra en Accure Therapeutics"},"content":{"rendered":"<p><a href=\"https:\/\/accure.health\/\" target=\"_blank\" rel=\"noopener\">Accure Therapeutics<\/a> ha iniciado su actividad en el \u00e1mbito del Sistema Nervioso Central (SNC) anunciando una primera ronda de financiaci\u00f3n de 7,6 M\u20ac. La empresa desarrollara\u0301 una cartera de medicamentos candidatos para el tratamiento de enfermedades del SNC, una de las principales causas de discapacidad y muerte en todo el mundo y cuya prevalencia incrementara\u0301 a causa del envejecimiento de la poblacio\u0301n.<\/p>\n<p>La empresa empezara\u0301 trabajando en tres programas de nuevos medicamentos centrados en dianas terap\u00e9uticas que provienen de Iproteos, spin-off de la Universidad de Barcelona (UB) y del Institute for Research in Biomedicine (IRB Barcelona) y de Bionure, spin-off del (Institut d&#8217;Investigacions Biom\u00e8diques August Pi i Sunyer) IDIBAPS y del Consejo Superior de Investigaciones Cient\u00edficas (CSIC). Tanto Iproteos como Bionure han quedado integradas en Accure Therapeutics.<\/p>\n<p>\u201cNos enorgullece anunciar el lanzamiento de Accure Therapeutics\u201d, apunta Laurent Nguyen, fundador y CEO de Accure Therapeutics. \u201cLos activos de alta calidad de nuestra cartera de productos cuentan con el potencial de cambiar las vidas de los pacientes que conviven con enfermedades discapacitantes del SNC. La vida es un regalo, asi\u0301 que debemos esforzarnos al ma\u0301ximo en respetarla\u201d, concluye.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Accure Therapeutics ha iniciado su actividad en el \u00e1mbito del Sistema Nervioso Central (SNC) anunciando una primera ronda de financiaci\u00f3n&#8230;<\/p>\n","protected":false},"author":2,"featured_media":9894,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-9895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualidad"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/posts\/9895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=9895"}],"version-history":[{"count":1,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/posts\/9895\/revisions"}],"predecessor-version":[{"id":9896,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/posts\/9895\/revisions\/9896"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/media\/9894"}],"wp:attachment":[{"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=9895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=9895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=9895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}